The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on August 25, 2026

Aug. 25, 2026

Flu Vaccines Now Available at All Stop & Shop Pharmacies Ahead of Respiratory Virus Season

Indeterminate GlobeNewswire

Aug. 25, 2026

Coralogix Adds Macquarie Capital Venture Capital as Investor to Accelerate Expansion Across Australia and New Zealand

Indeterminate GlobeNewswire

Aug. 25, 2026

Symbotic Joins Stanford Robotics Center Industrial Affiliates Program

Indeterminate GlobeNewswire

Aug. 25, 2026

Aflex Hose achieves EcoVadis Platinum status and top 1% global recognition

Indeterminate GlobeNewswire

Aug. 25, 2026

Salary.com Completes Workday Design Approved Integration, Giving Workday Customers Access to Global Compensation Management Software & Data

Indeterminate GlobeNewswire

Aug. 25, 2026

State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption

Indeterminate GlobeNewswire

Aug. 25, 2026

Rocket Software Advances AI Enablement for Application Modernization Across Mission-Critical Platforms

Indeterminate GlobeNewswire

Aug. 25, 2026

Flywire to Attend Upcoming Investor Conference

Indeterminate GlobeNewswire

Aug. 25, 2026

Advanced Smart Mobility Deploys Cerence Emergency Vehicle Detection in Autonomous Buses Across Japan

Indeterminate GlobeNewswire

Aug. 25, 2026

State of the Energy & Sustainability Industry to Reach New Inflection Point by 2026, Driven by Clean Hydrogen Acceleration, Blade Recycling Mandates, and Geopolitical Energy Disruption

Indeterminate GlobeNewswire

Aug. 25, 2026

Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium

Indeterminate GlobeNewswire

Aug. 25, 2026

Apollo Therapeutics Announces Positive Immunogenicity Data and Cross-Species Activity from Phase 1 Trial of APL-10456, a Pan-Rhinovirus Vaccine for the Prevention of COPD Exacerbations

Indeterminate GlobeNewswire

Aug. 25, 2026

Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors

Indeterminate GlobeNewswire

Aug. 25, 2026

Solar Energy Markets to Reach $974.7 Billion by 2031, Driven by Policy Mandates, Falling Costs, and Surging EV Infrastructure Demand

Indeterminate GlobeNewswire

Aug. 25, 2026

Akamai Announces Strategic Alliance with Deloitte Canada to Help Organizations Achieve Platform-Based Resilience Against AI-Accelerated Cyberthreats

Indeterminate GlobeNewswire

Aug. 25, 2026

State of the Materials Industry to Reach $87.6 Billion in Advanced Chip Packaging Alone by 2030, Driven by AI, Electrification, and Next-Generation Manufacturing Demand

Indeterminate GlobeNewswire

Aug. 25, 2026

AI-Driven Bioprinting Emerges as a High-Conviction Investment Theme as Corporate AI Spending Surpasses $252 Billion

Indeterminate GlobeNewswire

Aug. 25, 2026

Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study

Indeterminate GlobeNewswire